Atlas of axial spondyloarthritis in Spain 2017: Study design and population
Marco Garrido-Cumbrera, Victoria Navarro-Compán, Pedro Zarco, Eduardo Collantes-Estévez, David Gálvez-Ruiz, Olta Braçe, Jorge Chacón García, Carles Blanch Mur, Angels Costa Ferrer, Alvaro Hidalgo Vega, Pedro Plazuelo Ramos, Jord Gratacós Masmitja.
Clinical Rheumatology. 2019. 15:3:127-132
Objective
Atlas of Axial Spondyloarthritis in Spain 2017 aims to better understand the reality of the patients suffering from this disease from an integrated approach.
Methods
The Atlas 2017 based its results on an extensive cross-sectional patient survey conducted in Spain (2016), validated by a multidisciplinary group of experts on spondyloarthritis.
Results
Data from 680 patients with axSpA were obtained, most of them suffered from AS, were HLA-B27 positive, older than 45 years, and live as part of a couple. A large percentage had university studies, were disabled and members of a patient association. Patients reported a diagnostic delay of 8.5 years, high disease activity (BASDAI 5.5 ± 2.2), moderate-important stiffness (61.0%), medium-high functional limitation (74.9%), and psychological distress (GHQ 5.7 ± 4.5). A total of 54.7% reported taking NSAIDs, 28.4% DMARDs, 36.3% biological therapy and 32.2% were not receiving pharmacological treatment.
Conclusions
The Atlas survey data reveals still a long diagnostic delay, high disease activity, psychological distress, while an important proportion could be undertreated.
Link to the article:
